Table 3.
Lymphoid malignancy | Asian ethnic group | Nativity | Males | ||||
---|---|---|---|---|---|---|---|
Cases (N) | Incidence rate* | 95% CI | IRR | 95% CI | |||
Diffuse large B-cell lymphoma | |||||||
All | US-born | 314 | 8.5 | (7.5–9.5) | 1.00 | reference | |
Foreign-born | 961 | 6.5 | (6.1–7.0) | 0.77 | (0.67–0.88) | ||
Chinese | US-born | 96 | 10.9 | (8.6–13.6) | 1.00 | reference | |
Foreign-born | 257 | 4.7 | (4.1–5.4) | 0.43 | (0.33–0.57) | ||
Japanese | US-born | 149 | 6.7 | (5.6–8.0) | 1.00 | reference | |
Foreign-born | 49 | 11.5 | (8.0–15.7) | 1.71 | (1.14–2.46) | ||
Other Asian | US-born | 69 | 8.8 | (6.3–11.8) | 1.00 | reference | |
Foreign-born | 655 | 7.4 | (6.8–8.1) | 0.85 | (0.62–1.20) | ||
Non-Hispanic White | 12,636 | 8.8 | (8.7–9.0) | --- | --- | ||
| |||||||
Follicular lymphoma | |||||||
All | US-born | 96 | 2.7 | (2.1–3.3) | 1.00 | reference | |
Foreign-born | 244 | 1.5 | (1.3–1.7) | 0.57 | (0.44–0.73) | ||
Non-Hispanic White | 5,981 | 4.1 | (4.0–4.2) | --- | --- | ||
| |||||||
Chronic lymphocytic leukemia/small lymphocytic lymphoma | |||||||
All | US-born | 81 | 2.4 | (1.9–2.9) | 1.00 | reference | |
Foreign-born | 249 | 1.7 | (1.5–1.9) | 0.72 | (0.56–0.95) | ||
Non-Hispanic White | 11,094 | 7.9 | (7.8–8.1) | --- | --- | ||
| |||||||
T-cell lymphoma | |||||||
All | US-born | 122 | 2.2 | (1.8–2.7) | 1.00 | reference | |
Foreign-born | 305 | 2.0 | (1.8–2.3) | 0.91 | (0.71–1.18) | ||
Non-Hispanic White | 3,348 | 2.4 | (2.3–2.5) | --- | --- | ||
| |||||||
Multiple myeloma | |||||||
All | US-born | 128 | 3.8 | (3.2–4.5) | 1.00 | reference | |
Foreign-born | 614 | 4.3 | (4.0–4.7) | 1.14 | (0.94–1.41) | ||
Non-Hispanic White | 8,929 | 6.4 | (6.2–6.5) | --- | --- | ||
| |||||||
All Hodgkin lymphoma | |||||||
All | US-born | 105 | 1.8 | (1.4–2.2) | 1.00 | Reference | |
Foreign-born | 179 | 1.1 | (0.9–1.2) | 0.60 | (0.46–0.80) | ||
Non-Hispanic White | 4,929 | 3.4 | (3.3–3.5) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Age <45 years | |||||||
All | US-born | 82 | 1.7 | (1.3–2.2) | 1.00 | Reference | |
Foreign-born | 92 | 0.7 | (0.6–1.0) | 0.43 | (0.30–0.63) | ||
Non-Hispanic White | 3,010 | 3.2 | (3.1–3.3) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Age 45+ years | |||||||
All | US-born | 23 | 1.8 | (1.1–2.7) | 1.00 | Reference | |
Foreign-born | 87 | 1.6 | (1.3–2.0) | 0.90 | (0.55–1.51) | ||
Non-Hispanic White | 1,919 | 3.8 | (3.7–4.0) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Nodular sclerosis | |||||||
All | US-born | 64 | 1.0 | (0.8–1.4) | 1.00 | reference | |
Foreign-born | 92 | 0.5 | (0.4–0.7) | 0.53 | (0.36–0.79) | ||
Non-Hispanic White | 2,900 | 2.0 | (1.9–2.1) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Mixed cellularity | |||||||
All | US-born | 15 | 0.3 | (0.2–0.5) | 1.00 | reference | |
Foreign-born | 47 | 0.3 | (0.2–0.4) | 0.90 | (0.48–1.86) | ||
Non-Hispanic White | 1,001 | 0.7 | (0.7–0.7) | --- | --- |
Lymphoid malignancy | Asian ethnic group | Nativity | Females | ||||
---|---|---|---|---|---|---|---|
Cases (N) | Incidence rate* | 95% CI | IRR | 95% CI | |||
Diffuse large B-cell lymphoma | |||||||
All | US-born | 198 | 4.6 | (4.0–5.4) | 1.00 | reference | |
Foreign-born | 872 | 4.7 | (4.4–5.0) | 1.01 | (0.86–1.19) | ||
Chinese | US-born | 49 | 4.5 | (3.3–6.0) | 1.00 | reference | |
Foreign-born | 219 | 3.6 | (3.1–4.1) | 0.80 | (0.58–1.14) | ||
Japanese | US-born | 107 | 4.4 | (3.5–5.3) | 1.00 | reference | |
Foreign-born | 61 | 4.1 | (3.0–5.4) | 0.94 | (0.65–1.34) | ||
Other Asian | US-born | 42 | 5.1 | (3.3–7.4) | 1.00 | reference | |
Foreign-born | 592 | 5.5 | (5.0–5.9) | 1.07 | (0.73–1.66) | ||
Non-Hispanic White | 9,284 | 5.2 | (5.1–5.3) | --- | --- | ||
| |||||||
Follicular lymphoma | |||||||
All | US-born | 77 | 2.0 | (1.5–2.5) | 1.00 | reference | |
Foreign-born | 244 | 1.2 | (1.0–1.4) | 0.61 | (0.47–0.81) | ||
Non-Hispanic White | 6,046 | 3.5 | (3.4–3.6) | --- | --- | ||
| |||||||
Chronic lymphocytic leukemia/small lymphocytic lymphoma | |||||||
All | US-born | 44 | 1.2 | (0.8–1.6) | 1.00 | reference | |
Foreign-born | 186 | 1.0 | (0.9–1.2) | 0.87 | (0.56–0.95) | ||
Non-Hispanic White | 7,879 | 4.2 | (4.1–4.3) | --- | --- | ||
| |||||||
T-cell lymphoma | |||||||
All | US-born | 77 | 1.5 | (1.1–1.9) | 1.00 | reference | |
Foreign-born | 217 | 1.1 | (1.0–1.3) | 0.75 | (0.56–1.03) | ||
Non-Hispanic White | 2,106 | 1.3 | (1.2–1.3) | --- | --- | ||
| |||||||
Multiple myeloma | |||||||
All | US-born | 87 | 2.3 | (1.8–2.9) | 1.00 | reference | |
Foreign-born | 581 | 3.2 | (2.9–3.5) | 1.37 | (1.09–1.75) | ||
Non-Hispanic White | 7,428 | 4.0 | (3.9–4.1) | --- | --- | ||
| |||||||
All Hodgkin lymphoma | |||||||
All | US-born | 107 | 1.6 | (1.2–1.9) | 1.00 | Reference | |
Foreign-born | 125 | 0.6 | (0.5–0.7) | 0.38 | (0.28–0.52) | ||
Non-Hispanic White | 4,038 | 2.8 | (2.7–2.8) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Age <45 years | |||||||
All | US-born | 91 | 1.7 | (1.3–2.1) | 1.00 | Reference | |
Foreign-born | 71 | 0.5 | (0.4–0.7) | 0.29 | (0.20–0.43) | ||
Non-Hispanic White | 2,600 | 2.9 | (2.8–3.1) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Age 45+ years | |||||||
All | US-born | 16 | 1.3 | (0.7–2.1) | 1.00 | Reference | |
Foreign-born | 54 | 0.8 | (0.6–1.0) | 0.60 | (0.34–1.14) | ||
Non-Hispanic White | 1,438 | 2.4 | (2.3–2.5) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Nodular sclerosis | |||||||
All | US-born | 83 | 1.1 | (0.9–1.4) | 1.00 | reference | |
Foreign-born | 83 | 0.4 | (0.3–0.5) | 0.34 | (0.24–0.48) | ||
Non-Hispanic White | 2,908 | 2.1 | (2.0–2.1) | --- | --- | ||
| |||||||
Hodgkin lymphoma, Mixed cellularity | |||||||
All | US-born | 11 | --- | --- | 1.00 | reference | |
Foreign-born | 23 | 0.1 | (0.1–0.2) | 0.64 | (0.28–1.67) | ||
Non-Hispanic White | 531 | 0.3 | (0.3–0.4) | --- | --- |
Standardized to the 2000 U.S. population age standard. Incidence rates with numerator <15 are not computed.
CI: Confidence interval